DMAA Supplements Land GNC, USPLabs in Class Action

Share This:
 

GNC Corp. and USPLabs LLC face a potential class-action dangerous drug lawsuit filed by a California resident that alleged the companies sold unsafe dietary supplements containing DMAA (1,3-dimethylamylamine).

Law 360 (subscription required) reports that the suit claims the companies manufactured, marketed, and sold dietary supplements like Jack3d that contained DMAA, which is linked to cardiac problems, nervous system disorders, and death.

Though retailer GNC Corp. reports only one case of adverse side effect related to a DMAA containing product, its annual report discusses the concern that DMAA breaches the Dietary Supplement Health and Education Act, writes Law360.

According to the U.S. Food and Drug Administration (FDA), DMAA can constrict blood vessels and arteries, may cause heart attacks, strokes, and other life-threatening injuries. There have been 42 adverse events reported to the FDA over products containing DMAA.

The FDA sent warning letters in April to 10 manufacturers and distributors of products containing DMAA stating that it is not eligible to be used as an active ingredient in dietary supplements. If you or a loved one has been harmed by a dangerous supplement, contact Sokolove Law today for a free legal consultation and to find out if a dangerous drug lawyer may be able to able to help you.